Skip to main content
Industry News
Gilead plans easier-to-use remdesivir for COVID-19

Gilead Sciences announced that it's evaluating other ways it can use remdesivir for COVID-19 at an earlier stage of the disease, particularly through alternate formulations, such as one that's inhalable and a subcutaneous injection formulation.

Full Story: